1. Home
  2. AAT vs YDES Comparison

AAT vs YDES Comparison

Compare AAT & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAT
  • YDES
  • Stock Information
  • Founded
  • AAT 1967
  • YDES 2013
  • Country
  • AAT United States
  • YDES Taiwan
  • Employees
  • AAT N/A
  • YDES N/A
  • Industry
  • AAT Real Estate Investment Trusts
  • YDES
  • Sector
  • AAT Real Estate
  • YDES
  • Exchange
  • AAT Nasdaq
  • YDES Nasdaq
  • Market Cap
  • AAT 1.2B
  • YDES 1.1B
  • IPO Year
  • AAT 2011
  • YDES N/A
  • Fundamental
  • Price
  • AAT $20.11
  • YDES $15.00
  • Analyst Decision
  • AAT Hold
  • YDES
  • Analyst Count
  • AAT 2
  • YDES 0
  • Target Price
  • AAT $20.50
  • YDES N/A
  • AVG Volume (30 Days)
  • AAT 340.6K
  • YDES 43.8K
  • Earning Date
  • AAT 10-28-2025
  • YDES 09-30-2025
  • Dividend Yield
  • AAT 6.76%
  • YDES N/A
  • EPS Growth
  • AAT 37.34
  • YDES N/A
  • EPS
  • AAT 1.22
  • YDES N/A
  • Revenue
  • AAT $448,315,000.00
  • YDES $510,360.00
  • Revenue This Year
  • AAT N/A
  • YDES N/A
  • Revenue Next Year
  • AAT $4.03
  • YDES N/A
  • P/E Ratio
  • AAT $16.51
  • YDES N/A
  • Revenue Growth
  • AAT 1.71
  • YDES 45.76
  • 52 Week Low
  • AAT $16.69
  • YDES $5.30
  • 52 Week High
  • AAT $29.15
  • YDES $25.00
  • Technical
  • Relative Strength Index (RSI)
  • AAT 53.20
  • YDES N/A
  • Support Level
  • AAT $19.91
  • YDES N/A
  • Resistance Level
  • AAT $20.28
  • YDES N/A
  • Average True Range (ATR)
  • AAT 0.37
  • YDES 0.00
  • MACD
  • AAT 0.07
  • YDES 0.00
  • Stochastic Oscillator
  • AAT 87.31
  • YDES 0.00

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: